FeNOMENAL is the first technology to bring to life an individual’s risk of asthma attack with a unique combination of data visualization and sound design. Correlating individual raw FeNO scores to a custom algorithm of shapes, colors, and sounds turns the lung’s distress into a 360-degree sensory experience. Design patterns mimic bronchial constriction so visitors can easily correlate the visualized data with their pathophysiology. A breath-inspired soundscape uses environmentally recorded wind tones, wind instruments, and other harmonic layers that oscillate to reflect a range of scores from calm (mild) to intense (severe). Holophonic headsets enable a more immersive experience.

Sanofi puts all content through a rigorous review process, and for Global initiatives, it is reviewed both at the global and local level. For FeNOMENAL, the core global team reviewed the work, but it was also reviewed and approved by each local market where it launched (Spain, China, and Brazil). All visuals, data, collateral, structural design and anticipated content generation was approved by legal, medical, and regulatory bodies across each country. Additionally, rigor was put behind translation of materials for each market.

Too often, messaging and activations that encourage patients to take control of their condition are done through fear, scare tactics, or blame. The Sanofi team engaged patients at the hospital: a place most known for an asthma emergency. They used this public, yet nontraditional venue to create an insightful moment that not only educated, but inspired patients to take action with their newfound FeNO knowledge.

Across global markets, engaging patients in healthcare communications and activations in a regulated environment such as asthma is challenging. This, coupled with the stigma of asthma across cultures make it difficult for people to stay informed on their own level of risk. To ensure credibility, we first had to rally the healthcare community within a given hospital setting. Once introduced to the validity and practical application of the FeNOMENAL experience, HCPs readily embraced the opportunity to participate in the program and to serve as facilitators for patients.

FeNOMENAL turned what could have been a frightening, fearful moment of recognition into a calming but informative experience where people voluntarily participated, had an experience they would remember, and were empowered through the on-site care team and through their personalized collateral and read-out to take control and take action. The data visualization and auditory ques were gentle, but impactful. The materials encouraged patients to talk to their doctor and make a plan if their FeNO score was high. Sanofi created an experience that patients valued for the experience, the insight, and the impact on their life.

Sanofi regulatory committee consisting of legal, media and regulatory. The rules for disease state education are strict. We cannot mention any treatment change or brand name as a result of testing scores.

Our primary audience was people with asthma passing through hospitals of Spain, and then scaled up globally. The installation also attracted Healthcare Professionals in the hospitals. We expanded the program to institutions in China and Brazil in preceptorships and congresses to educate HCPs on the value of screening for FeNO.

Every 10 minutes someone dies from an asthma attack. High FeNO, a marker of airway inflammation, is linked to 3x greater risk of attacks. Although a FeNO test is simple and non-invasive (patients exhale into a tube), the test is not yet widely used by HCPs or understood by patients.

Our client briefed us to create an idea that could be implemented in a hospital that would drive home the importance of FeNO for asthma control to both doctors and patients. It was piloted in Spain, with scalability for other global markets.

Commercial objectives were to elevate understanding and screenings for the FeNO biomarker within certain communities. Marketing objective was to educate patients who suffer from asthma to better understand their level of risk for an attack, and what the role of inflammation is in their body. Communications objective was to generate awareness in specific regions, across patients and physicians.

Using Data Visualization and Audio Design, the FeNOMENAL experience allows patients to see and hear their asthma risk in a way that inspires them to take action. We correlated individual raw scores to shapes, colors, and sounds that emphasized the lung’s distress. Implemented across the world at hospitals and in clinical settings, FeNOMENAL urges asthma patients with elevated FeNO to talk with their doctor about a plan that could save their life.

The brief was to raise awareness of FeNO in hospital systems, and the expectation was typical advertising. We took the most important aspect of the awareness – an individual’s own score – and created an unforgettable experience that allowed patients and passersby to discover if they were at risk and to become aware, empowered, and ready to take control of their disease.

Although the FeNO test is simple and non-invasive, the test is not yet widely used by HCPs or understood by patients. This score is a strong indicator for risk of asthma inflammation, which leads to an attack. To draw attention to, and ease patients in to what could be an alarming concept, we pulled them into the experience in a comforting, calming way. They were able to immerse themselves in their own data, providing a compelling and memorable way to learn about what their score meant. They were also able to see their own score mapped against others in their region to understand where they stood in the general population. After the experience, they were empowered with tools to bring to their doctor to discuss their score and make a plan.

Using custom Data Visualization and Audio Design the FeNOMENAL experience allows patients to see and hear their own risk, in a way that inspires them to take action. Individual raw scores correlated to an algorithm of shapes, colors, and sounds that turned the lung’s distress into a surround sound sensory experience. Patients gained insight into their personal score and saw it mapped against others in their region. FeNOMENAL partnered NIOX, global leader in FeNO testing, with hospitals and advocacy groups across the world to create a new standard of asthma education.

FeNOMENAL kicked off on World Asthma Day and traveled to hospitals in Bilbao, Madrid, Barcelona, and Seville, Spain. After that, it scaled to congresses and preceptorships for HCPs and Patients across Curitiba, Sao Paolo, Brazil; Shanghai, China.

Over 500 patients were tested and hundreds of HCPs are using learning modules designed to educate on the value of FeNO testing.

17% of people who participated in FeNOMENAL events learned they were at risk for an asthma attack. Patients gained insight into their personal score, and were able to see their score mapped against others in their region. FeNOMENAL partnered NIOX, global leader in FeNO testing, with hospitals and advocacy groups across the world to create a new standard for asthma education.and were empowered to talk with their doctor about a plan that could save their life. Globally, more than 257 Million impressions were made across 110 publications.